Kevin F. Mclaughlin
Director at Vericel · 7 reported transactions in 2 companies · latest trade Feb 11, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −53.6%, S&P 500 +12.9% over the same days.
Their trades
Sold | Feb 11, 2026 | Feb 11, 2026 close $34.63 → Oct 28, 2026 close $41.09. S&P 500 +11.6% over the same days. | ||
Bought | Nov 19, 2025 | Nov 19, 2025 close $2.50 → Oct 28, 2026 close $0.62. S&P 500 +16.6% over the same days. | ||
Sold | Nov 10, 2025 | Nov 10, 2025 close $38.99 → Oct 28, 2026 close $41.09. S&P 500 +13.3% over the same days. | ||
Sold | Aug 6, 2025 | Aug 6, 2025 close $36.29 → Oct 28, 2026 close $41.09. S&P 500 +22.1% over the same days. |
SoldVericel
$242.6K
Feb 11, 2026 close $34.63 → Oct 28, 2026 close $41.09. S&P 500 +11.6% over the same days.
BoughtInvivyd
$125K
Nov 19, 2025 close $2.50 → Oct 28, 2026 close $0.62. S&P 500 +16.6% over the same days.
SoldVericel
$270.1K
Nov 10, 2025 close $38.99 → Oct 28, 2026 close $41.09. S&P 500 +13.3% over the same days.
SoldVericel
$251.4K
Aug 6, 2025 close $36.29 → Oct 28, 2026 close $41.09. S&P 500 +22.1% over the same days.